Inovio pharma says filed complaint seeking to compel vgxi inc & geneone life scienc to facilitate transfer of manufacturing methods

Inovio pharma - filed complaint seeking to compel vgxi, inc & geneone life scienc to facilitate transfer of manufacturing methods, using vgxi's technology.inovio pharma - technology transfer as permitted under agreement to allow for large-scale manufacture of co's vaccine candidate ino-4800 against covid-19.inovio pharmaceuticals inc - has a goal of producing one million doses of ino-4800 by end of 2020.inovio pharmaceuticals - vgxi informed co it did not have capacity to manufacture co's full order of dna plasmids on requested timeline.inovio pharma - vgxi informed co it would not be able to manufacture plasmids for commercial sale of ino-4800, if it were to be approved for sale.inovio pharmaceuticals - began discussions with other third-party contract manufacturers, as permitted by supply agreement.inovio pharmaceuticals - intends to engage additional contract manufacturers for production of ino-4800.
INO Ratings Summary
INO Quant Ranking